We generated patient cSCC-derived xenografts (cSCC-PDXs) that recapitulate the histopathologic and molecular features of parental patient samples. Response to gefitinib treatment was tested in four in
Diffuse large B-cell lymphoma (DLBCL) is the most common B-cell non-Hodgkin lymphoma and remains incurable in ~40% of patients. Coding-genome sequencing efforts identified several genes/pathways alter
Genomic locations analyzed. This table contains the bisulfite PCR primer sets used along with the restriction enzyme used for each PCR product. (XLSX 17Â kb)
